Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia.
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersmicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorderEpigenetic principles and mechanisms underlying nervous system functions in health and diseaseStriatal microRNA controls cocaine intake through CREB signallingMicroRNAs in addiction: adaptation's middlemen?Physiological stressors and invasive plant infections alter the small RNA transcriptome of the rice blast fungus, Magnaporthe oryzae.RDMAS: a web server for RNA deleterious mutation analysis.Brain expressed microRNAs implicated in schizophrenia etiology.A novel representation of RNA secondary structure based on element-contact graphs.MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia.MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disordersGenome-wide analysis of attention deficit hyperactivity disorder in Norway.Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivationRegulatory RNAs in brain function and disorders.The Role of MicroRNAs in Human DiseasesSublethal RNA oxidation as a mechanism for neurodegenerative diseaseMicroRNAs: a new class of gene regulators.Recent computational approaches to understand gene regulation: mining gene regulation in silico.Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder.Group II metabotropic glutamate receptors and schizophrenia.Oxidative damage to RNA in aging and neurodegenerative disorders.Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs.microRNAs as novel biomarkers of schizophrenia (Review)Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics.MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets.Emerging roles for ncRNAs in alcohol use disorders.Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population.
P2860
Q21129476-FA01BB00-39FD-4350-B06F-6745DB8D027EQ21184126-E56171B4-78FD-484D-A115-9E0C29B7B550Q24657549-48A82062-2794-4B86-A354-23CE9F2C5529Q28397558-92DDA988-A63D-455C-BEE1-4F311E2C4CBBQ30409196-AF2ACA90-DEA0-47CD-807A-31DDFE05480DQ30624212-EFBC2E00-0EFB-41CC-99AF-35F0CBF51CF6Q33256565-80467A07-D646-4DE6-99C0-F3E500308FE5Q33298597-7982BA55-5BF3-41A4-91AA-BA8B94F83A9DQ33327606-1D349807-8EAA-4481-BFDA-FB1B229D8DFDQ33955198-5C86F375-1132-41DB-8AAF-B5515D124308Q35216295-ECBB25AF-1D5A-4F32-8470-B37FA3E20061Q35393713-77473070-73D5-42A0-AFA8-A1D8CED12465Q35596962-6F903F4B-A7FD-4546-AD0A-5F692FBCA26CQ36474429-947D03AE-BA49-45F4-9FAC-FD2887111FB0Q36571349-281AE9F3-E928-4FAD-AD48-9C2F747FFCC9Q37083453-1C673B09-14BD-46E8-AC0C-4D59F5D8F3D2Q37126078-D8E2A4B0-7B44-40A2-A39F-A899906A82FFQ37228388-38D568BD-9E98-4BA1-B18A-A14A5026FFB4Q37352439-69FFFFF9-186B-497A-8DD7-9D89778B4002Q37473779-B73CB6AC-6E99-4F26-9C3E-B7397248753AQ38016374-706B0029-B173-44C2-8827-8767928BDA12Q38068561-911BEBBF-83AE-4CE7-8CB9-4C3062C43E25Q38265172-803352AC-095D-4B6D-AB85-B539BD36C901Q38767128-C882C48B-39D8-4FCA-97FF-EEF0B343EBADQ38843644-C4010FB4-3A4D-48D8-8E15-4DAC697ECCA5Q38989183-04ED5162-1E56-43D3-B913-7639F211B814Q39259460-AD76D89F-CB8A-404C-8FED-4C096DCDEA74Q40859327-0448B55B-45C3-40F4-BE2C-608927FDF6C3Q41611297-F67CDDFC-3BA7-40A2-8E26-7BA5EDF37681Q46422249-F9C2F017-CC15-4FD2-BC24-43E8B66A3DC7Q48624606-BA5A6B0F-ED13-40E3-88EC-EE60BB1F41D6
P2860
Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@ast
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@en
type
label
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@ast
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@en
prefLabel
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@ast
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@en
P2093
P2860
P356
P1433
P1476
Expanding the 'central dogma': ...... ic liability to schizophrenia.
@en
P2093
Jeffries C
Perkins DO
Sullivan P
P2860
P2888
P356
10.1038/SJ.MP.4001577
P407
P577
2005-01-01T00:00:00Z